Legislator Rechtsprechung & Gesetzgebung
ln_2021_112 MT

Drugs (Control) (Amendment) Regulations, 2021

4 Artikel / Bestimmungen · Malta
Originalquelle öffnen Maschinenlesbares Markdown (.md)

Gesetzestext (4 Artikel)

Malta Government Gazette — Legal Notice 2021 112 · Gazzetta tal-Gvern ta’ Malta Nru. 20,591 – 17.03.2021<P Class=Msonormal — Drugs (Control) (Amendment) Regulations, 2021

L.N. 112 of 2021

MEDICAL AND KINDRED PROFESSIONS ORDINANCE

(CAP. 31)

Drugs (Control) (Amendment) Regulations, 2021

IN EXERCISE of the powers conferred by article 40 of the

Medical and Kindred Professions Ordinance, the Minister for Health

after consultation with the Council of Health, has made the following

regulations:-

Malta Government Gazette — Legal Notice 2021 112 · Gazzetta tal-Gvern ta’ Malta Nru. 20,591 – 17.03.2021<P Class=Msonormal — Drugs (Control) (Amendment) Regulations, 2021

The title of these regulations is Drugs (Control) Citation.

(Amendment) Regulations, 2021 and these regulations shall be read

and construed as one with the Drugs (Control) Regulations, hereinafter S.L. 31.18.

referred to as "the principal regulations".

Malta Government Gazette — Legal Notice 2021 112 · Gazzetta tal-Gvern ta’ Malta Nru. 20,591 – 17.03.2021<P Class=Msonormal — Drugs (Control) (Amendment) Regulations, 2021

In the First Schedule to the principal regulations, there shall Amends the

First Schedule

be added the following

to the principal

regulations.

International or other

nonproprietary name or

Chemical name

other trivial name

"DOC

1-(4-chloro-2,5-dimethoxyphenyl)propan-

2-amine".

Malta Government Gazette — Legal Notice 2021 112 · Gazzetta tal-Gvern ta’ Malta Nru. 20,591 – 17.03.2021<P Class=Msonormal — Drugs (Control) (Amendment) Regulations, 2021

In the Second Schedule to the principal regulations, there Amends the

Second

shall be added the following

Schedule to the

principal

regulations.

International or other

nonproprietary name or

Chemical name

other trivial name

"AB-FUBINACA (or

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-

FUB-AMB)

(4-fluorobenzyl)-1H-indazole-3-carboxam-

ide

5F-AMB-PINACA (or 5F- methyl 2-({[1-(5-fluoropentyl)-1H-indazole-

AMB or 5F-MMB-PIN-

3-yl]carbonyl}amino)-3-methylbutanoate

ACA)

5F-MDMB-PICA (or 5F- methyl 2-{[1-(5-fluoropentyl)-1H-indole-3-

carbonyl]amino}-3,3-dimethylbutanoate

MDMB-2201)

4F-MDMB-BINACA (or methyl 2-{[1-(4-fluorobutyl)-1H-indazole-3-

4F-MDMB-BUTINACA) carbonyl]amino}-3,3-dimethylbutanoate

4-CMC (or 4-chlorometh- 1-(4-chlorophenyl)-2-(methylamino)pro-

cathinone or clephedrone) pan-1-one

N-ethylhexedrone (or

2-(ethylamino)-1-phenylhexan-1-one

NEH, Hexen, Ethyl-Hex,

Ethyl-hexedrone)

Alpha-PHP (or PV-7, α-

1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one

PHP, α-pyrrolidinohexan-

ophenone)

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-

Flualprazolam (or Ro 11-

[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

5073/000)

Etizolam (or Y-7131 or

4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-

thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diaze-

Depas)

pine".

€0.18

Fragen Sie sich, wie diese Gesetzesbestimmung auf Ihren Fall anwendbar ist?

Prüfen Sie diesen Erlass zusammen mit Rechtsprechung, Kommentaren und verwandten Gesetzesbestimmungen in Legislator AI.

Fall in Legislator öffnen →